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Introduction
Neural crest is a transient structure in vertebrate embryos. The neural crest cells arise within the neural fold, migrate ventrally and laterally, and contribute significantly to a wide variety of cell types, such as peripheral neurons and their glial cells, pigment cells, skeletal derivatives, and smooth muscle cells (Le Douarin and Kalcheim, 1999; Hall, 1999) . Mesencephalic neural crest cells migrate beneath the lateral ectoderm and populate the trigeminal ganglia or the mandibular arch to differentiate into sensory neurons, glia, and chondrocytes (Chan and Tam, 1988; Osumi-Yamashita et al., 1994; Kubota et al., 1996; Cerny et al., 2004) .
It has been demonstrated that the activation of Notch signaling promotes the gliogenic specification of neural crest cells (Morrison et al., 2000; Ota and Ito, 2006; Ijuin et al., 2008) and this activation is stimulated by fibroblast growth factors (FGFs; Ota and Ito, 2006; Ijuin et al., 2008; Sugiura and Ito, 2010) . Notch signaling is an evolutionally conserved mechanism that influences various biological processes, such as cell fate specification, differentiation, proliferation, and apoptosis (Artavanis-Tsakonas et al., 1999; Miele and Osborne, 1999; Maynard et al., 2000; Wakamatsu et al., 2000) . Notch signaling is also known to have different Notch receptor downstream pathways, including Deltex-dependent and RBP-J-dependent pathways (Matsuno et al., 1995; Yamamoto et al., 2001; Kato et al., 1997) . Our previous study showed that the Deltex-dependent pathway but not the RBP-J-dependent pathway promotes gliogenesis through the activation of mammalian hairy and enhancer of split homologs (Hes)-1 and Hes-5 (Ijuin et al., 2008) , which are target transcription factors of Notch signaling and regulate cell differentiation (Sasai et al., 1992; Ishibashi et al., 1994; Ohtsuka et al., 1999) .
0925-4773/$ -see front matter Ó 2011 Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.mod.2011.09.003 Percentage of GFAP-expressing cells per total cells in a mouse mesencephalic neural crest cell colony (each colony was derived from a primary explant). Neural crest cells were treated with FGF2, the Notch-IC expression vector, the dn NF-jB expression vector, NF-jB siRNA and/or control siRNA during the first 48 h in culture. Immunostaining with anti-GFAP was performed on culture day 4. The asterisks show statistically significant differences (P < 0.05, t-test) from the proportion of anti-GFAP-positive cells in the cultures treated with FGF2. (B) Percentage of cells expressing GFAP per total cells in a neural crest cell colony. Neural crest cells were treated with the Notch-IC expression vector, the dn NF-jB expression vector, NF-jB siRNA, and/or control siRNA during the first 48 h in culture. Immunostaining with anti-GFAP was carried out on culture day 4. The asterisks show statistically significant differences (P < 0.05, t-test) from the proportion of anti-GFAP-positive cells in the cultures treated with the Notch-IC expression vector. (C) Percentage of anti-GFAP-positive cells per total cells in a neural crest cell colony. Neural crest cells were treated with FGF2, the dn NF-jB expression vector, the Deltex-1 expression vector, the Hes1 expression vector, and/or the Hes5 expression vector during the first 48 h in culture. Immunostaining with anti-GFAP was carried out on culture day 4. The asterisks indicate statistically significant differences (P < 0.05, t-test) from the proportion of anti-GFAP-positive cells in untreated cultures. (D) Percentage of anti-GFAP-positive cells per total cells in a neural crest cell colony. Neural crest cells were treated with the NF-jB expression vector, the dn Deltex-1 expression vector, Deltex-1 siRNA, and/or control siRNA during the first 48 h in culture. Immunostaining with anti-GFAP was performed on culture day 4. The asterisks show statistically significant differences (P < 0.05, t-test) from the proportion of anti-GFAP-positive cells in the cultures treated with the NF-jB expression vector. Data are expressed as the average (±SEM) of separate counts of 5-15 colonies (the number in parentheses on each bar). Each experiment was performed 2-6 times. Nuclear factor-jB (NF-jB), a transcription factor, is involved in carcinogenesis (Inoue et al., 2007; Van Waes, 2007) , inflammation (Delerive et al., 1999; Altman et al., 2008) , and autoimmunity (O'Sullivan et al., 2007) . Furthermore, this transcription factor plays important roles in neuronal and glial cell function (O'Neill and Kaltschmidt, 1997; Mé met, 2006). 
G). (I) DAPI-nuclear stain in the same field as (G) and (H). (J) Merged image of (G), (H), and (I). (K) Percentage of
Sox10-expressing cells that express Deltex-1 per total Deltex-1-expressing cells in a neural crest cell colony. The asterisks indicate statistically significant differences (P < 0.05, t-test) from the proportion of cells containing both Sox10 and Deltex-1 in untreated cultures. Data are expressed as the average (±SEM) of separate counts of 4-8 colonies (the number in parentheses on each bar). Each experiment was performed 2-3 times. Scale Bars = 50 lm.
The NF-jB family consists of five proteins, p65 (RelA), RelB, cRel, NF-jB1 (p105/p50), and NF-jB2 (p100/p52), which form homo-or heterodimers (Campbell and Perkins, 2006; Perkins, 2007) . Moreover, these dimers interact physically with inhibitor of jB (IjB) and are sequestered in the cytoplasm by masking the nuclear localization sequence of NF-jB (Beg and Baldwin, 1993; Hayden and Ghosh, 2004; Perkins, 2007) . Recent studies have shown that Notch signaling interacts with the NF-jB signaling pathway and regulates NF-jB activity (Osipo et al., 2008) . Furthermore, NF-jB promotes the expression of components downstream of the Notch receptor (Moran et al., 2007) . In the present study, therefore, we analyzed the interaction between NF-jB signaling and Notch signaling in the gliogenic specification of mouse mesencephalic neural crest cells.
Results

NF-jB promotes gliogenesis
To examine whether or not NF-jB signaling is required for gliogenesis, neurogenesis, and chondrogenesis, mouse mesencephalic neural crest cells were cultured in the presence of the NF-jB expression vector (1 lg of the pCG-BL encoding the p65 subunit of NF-jB and 1 lg of the pCG-BL encoding the p50 subunit of NF-jB). When the NF-jB expression vector was added to the cultures, there was a significant increase in the number of cells expressing p65 subunit of NF-jB ( Fig. 1S-U) . The previous studies have been shown that the exposure to FGF2 for the first 24 h and 48 h in culture is essential for chondrogenic and gliogenic specification, respectively (Nakanishi et al., 2007; Ijuin et al., 2008; Sugiura and Ito, 2010) . Furthermore, FGF2 treatment has been shown to prevent the neurogenesis of mouse neural crest cells (Ota and Ito, 2006; Nakanishi et al., 2007) . FGF2 or the NF-jB expression vector was added during the first 24 h or 48 h in culture. After 4 days in culture, we performed the immunocytochemical analysis using anti-glial fibrillary acidic protein (anti-GFAP) and anti-neurofilament 68 kDa and counted the number of cells containing GFAP and neurofilament 68 kDa, which are excellent markers of glial (Jessen et al., 1990 ) and neuronal differentiation. The percentage of cells expressing GFAP per neural crest cell colony (each colony was derived from a primary explant) significantly increased in the addition of the NF-jB expression vector, similar to FGF2 treatment . On the other hand, the treatment with FGF2 or the NF-jB expression vector suppressed neuronal differentiation (Fig. 1G-L and W) . Furthermore, we analyzed the expression of collagen type II, which is a marker of chondrogenesis, on culture day 7. Whereas the percentage of cells expressing collagen type II per neural crest cell colony increased in the presence of FGF2, treatment with the NF-jB expression vector had no effect on chondrogenesis (Fig. 1M-R and X) . These results suggest that NF-jB may promote gliogenesis but not neurogenesis and chondrogenesis. Therefore, we analyzed the roles of NF-jB signaling in the gliogenesis of mouse mesencephalic neural crest cells in more detail.
2.2.
Promotion of gliogenesis by NF-jB overexpression is not due to the selective growth of glia Since the number of glia was significantly increased by treatment with the NF-jB expression vector, we examined the effects of NF-jB on the proliferation of mouse mesencephalic neural crest cells using the 5-bromo-2 0 -deoxyuridine (BrdU) incorporation method to confirm that this increase is not due to the selective growth of glial precursor cells by NF-jB activity. Whereas the percentage of BrdU-incorporated cells was increased by treatment with the NF-jB expression vector for the first 48 h in culture (Fig. 2D ), the addition of this vector had no effect on the proliferation of GFAP-expressing cells, as shown by double-labeling experiments using anti-GFAP and anti-BrdU ( Fig. 2A-C and E) . In order to verify the cause of the increase of the BrdU-incorporated cell number by treatment with the NF-jB expression vector, we examined the percentage of BrdU-incorporated cells in NF-jB-positive cells or in NF-jB-negative cells by double-staining using anti-BrdU and anti-NF-jB (anti-p65 subunit of NF-jB). The percentage of BrdU-incorporated cells was higher in NF-jBpositive cells than that in NF-jB-negative cells ( Fig. 2F-I ). Thus, it is possible that the increase of the proliferation of the neural crest cells by treatment with the NF-jB expression vector is due to the increase of the proliferation of NF-jB-positive cells other than glial progenitor cells. In the 4 0 6-diamidino-2-phenylindole (DAPI) nuclear-staining experiments, furthermore, almost no cell death was observed under treatment with the NF-jB expression vector.
NF-jB acts on the pathway downstream of the Notch receptor
The gliogenic specification of mouse mesencephalic neural crest cells is promoted by FGF2 through Notch activation (Ijuin et al., 2008; Sugiura and Ito, 2010) . Therefore, it is conceivable that NF-jB signaling interacts with FGF and/or Notch signaling to promote gliogenesis. To examine whether or not there exists an interaction with FGF and/or Notch signaling, the neural crest cell cultures were treated with the dominant negative (dn) NF-jB expression vector (the Rc-CMV encoding the dn p50 subunit of NF-jB) p50 or NF-jB small interfering (si) RNA (si RNA of p50 subunit of NF-jB) in the presence of FGF2 or the Notch intracellular domain (Notch-IC) expression vector during the first 48 h in culture. The expression of GFAP was significantly suppressed by treatment with the dn NF-jB expression vector or NF-jB siRNA ( Fig. 3A and B) . This suppression was rescued by the addition of the expression vectors of Deltex-1, Hes1, or Hes5 (Fig. 3C) , which are the downstream factors of the Notch receptor and participate in gliogenesis (Ijuin et al., 2008) . Furthermore, treatment with the dn Deltex-1 expression vector or Deltex-1 siRNA inhibited the promotion of gliogenesis by NF-jB (Fig. 3D) .
FGF2 and Notch signaling activate NF-jB
We examined whether or not FGF2 and Notch signaling actually activate NF-jB by luciferase reporter assays. Mouse mesencephalic neural crest cell cultures were treated with the pGL4.32[luc2P/NF-jB-RE/Hygro] vector encoding the firefly luciferase reporter gene (luc2P) driven by five copies of an NFjB enhancer element during the first 48 h in culture. The number of cells expressing luciferase was significantly increased by treatment with FGF2 or the Notch-IC expression vector (Fig. 4A-D) . When the neural crest cells were treated with the control vector (pGL4.27[luc2P/minP/Hygro]), the number of luciferase-expressing cells was unchanged under any of the conditions examined (Fig. 4E) . Furthermore, we immunostained the neural crest cells using antibodies against luciferase, NF-jB, and Sox10 to investigate whether or not NF-jB activation by FGF2 or the Notch-IC expression vector treatment occurred in neural-crest-cell-derived glial progenitor cells. Sox10 is a marker for glial progenitor cells (Kuhlbrodt et al., 1998) . When the neural crest cell cultures were treated with the pGL4.32[luc2P/NF-jB-RE/Hygro] vector, the cells expressing both luciferase and Sox10 were observed under any of the conditions (Fig. 4F-I) . However, the proportion of anti-Sox10-positive glial progenitor cells in cells expressing luciferase was significantly increased by treatment with FGF2 or the Notch-IC expression vector during the first 48 h in culture (Fig. 4N) . Moreover, the percentage of Sox10-expressing cells in anti-NF-jB-positive cells was also increased by treatment with FGF2 or the Notch-IC expression vector (Fig. 4J-M and O) .
2.5.
NF-jB stimulates Deltex-1 expression NF-jB is known to promote Deltex expression in B lymphocytes (Moran et al., 2007) . We analyzed whether or not NF-jB can also stimulate Deltex expression in mouse mesencephalic neural crest cells. When the expression of Deltex-1 was examined by immunocytochemistry using anti-Deltex-1, the number of cells expressing Deltex-1 was significantly increased by transfection of the NF-jB expression vector during the first 48 h in culture (Fig. 5A-C) . By contrast, addition of the dn NF-jB expression vector prevented the promotion of Deltex-1 expression by the Notch-IC expression vector (Fig. 5D-F) . Furthermore, the number of anti-Sox10-positive glial progenitor cells expressing Deltex-1 was significantly increased by treatment with FGF2 or the Notch-IC expression vector during the first 48 h in culture (Fig. 5G-K ).
IjB suppresses gliogenesis
The previous studies have shown that Notch-IC activates NF-jB (Oakley et al., 2003) by inhibiting the activity of IjB, which down-regulates NF-jB activity (Nolan et al., 1991; Jacobs and Harrison, 1998) . The present data suggest that NFjB activation by Notch-IC also occurs in the gliogenesis of mouse mesencephalic neural crest cells. Therefore, we analyzed the roles of IjB in gliogenesis. The transfection of the wild-type IjBa expression vector for the first 48 h in culture significantly inhibited GFAP expression despite the presence of FGF2 or the Notch-IC expression vector ( Fig. 6A and B) . Furthermore, we treated the neural crest cell cultures with the super repressor (SR) IjBa, which IjB kinase (IKK) is unable to phosphorylate and which therefore never undergoes degradation (Traenckner et al., 1995; Ferreira et al., 1999) . The treatment with the SR IjBa expression vector also dramatically suppressed gliogenesis (Fig. 6A and B) .
2.7.
Notch-IC interacts with Deltex-1 in gliogenesis
Since NF-jB is likely to act on the pathway downstream of the Notch receptor, we thought that addition of the NFjB expression vector would restore the suppression of gliogenic specification by FGF signaling inhibitors (Sugiura and Ito, 2010) . However, the treatment with specific FGF signaling inhibitors, PD98059 (Dudley et al., 1995) and rapamycin (Hosoi et al., 1999) , during the first 48 h in culture suppressed GFAP expression despite the presence of the NF-jB expression vector (Fig. 7A) . Furthermore, the inhibition of gliogenesis by treatment with Notch-1 siRNA was not also rescued by addition of the NF-jB expression vector (Fig. 7B) . Interestingly, the suppression by FGF signaling inhibitors was restored by the addition of the Notch-IC expression vector (Fig. 7A ). Since Deltex has been shown to interact with the Notch-IC ankyrin repeats and to act as a positive regulator of Notch signaling (Matsuno et al., 1995) , it is conceivable that Notch-IC not only stimulates Deltex-1 expression through the activation of NF-jB signaling but also promotes gliogenesis by the interaction with Deltex-1. To analyze the interaction of Notch-IC with Deltex-1 in gliogenesis, we blocked the formation of Notch-IC by using Notch-1 siRNA in the presence of the Deltex-1 expression vector. The treatment with Notch-1 siRNA in the presence of the Deltex-1 expression vector for the first 48 h in culture drastically suppressed GFAP expression (Fig. 7C) . On the other hand, transfection of the Deltex-1 expression vector only promoted GFAP expression (Fig. 7C) . Since fetal bovine serum (FBS) and/or extract of day 11 chick embryos (CEE) in the present culture medium exhibited FGF activity (Sugiura and Ito, 2010), a small but not negligible amount of Notch-IC may be produced by this FGF activity and interact with the Deltex-1 provided by the Deltex-1 expression vector for the promotion of gliogenesis. To examine this notion, we prevented FGF signaling with SU5402, a specific inhibitor blocking FGF receptor tyrosine kinase activity (Mohammadi et al., 1997) , in the presence of the Deltex-1 expression vector. SU5402 treatment suppressed GFAP expression (Fig. 7C) . Immunostaining with anti-GFAP was carried out on culture day 4. The asterisks indicate statistically significant differences (P < 0.05, t-test) from the proportion of anti-GFAP-positive cells in the cultures transfected with the Deltex-1 expression vector. Data are expressed as the average (±SEM) of separate counts of 5-15 colonies (the number in parentheses on each bar). Each experiment was performed 2-6 times.
Presumptive trigeminal ganglia contain glial progenitor cells expressing NF-jB and Deltex-1
We investigated the expression patterns of p65 subunit of NF-jB, Deltex-1, and Sox10 in the presumptive trigeminal ganglionic region of the mouse embryo at embryonic day (E) 8.5-9.5 (12-28 somite stages), where mouse mesencephalic neural crest cells colonize and undergo gliogenesis. At 20-somite stage, the expression of NF-jB started to be observed in this region and cells containing Sox10, NF-jB, and Deltex-1 were found at 22-28 somite stages (Fig. 8A) , as shown by double-staining experiments with anti-NF-jB and anti-Sox10 or with anti-Deltex-1 and anti-Sox10. Furthermore, we found anti-Sox10-positive glial progenitor cells containing both NF-jB and Deltex-1 in neighboring sections of presumptive trigeminal ganglia at 22-26 somite stages (Fig. 8B-K 0 ). However, no Sox10-positive cells that express both NF-jB and Deltex-1 were observed at 28-somite stage.
Discussion
NF-jB promotes the gliogenic specification of mouse mesencephalic neural crest cells
In the present study, we showed that NF-jB signaling plays an important role in the gliogenesis of mouse mesencephalic neural crest cells. The overexpression of NF-jB stimulated GFAP expression of these cells. Since this stimulation was suppressed by siRNA of p50 subunit of NF-jB, it is obvious that p50 participates in gliogenic specification. Furthermore, p50 has been known to form heterodimer with p65 subunit of NF-jB (Urban et al., 1991; Perkins, 2007) . Therefore, p50-p65 heterodimer may promote gliogenesis of the neural crest cells. Proliferation of the neural crest cells was promoted by treatment with the NF-jB expression vector. This promotion may be due to the growth of neural stem cells by NF-jB activation, as shown by Wiedra et al. (2006) . On the other hand, GFAP-expressing cells labeled with BrdU were unchanged under NF-jB activation. Furthermore, almost no cell death was found under this treatment. Thus, the increase in the number of GFAP-positive cells is due to the promotion of gliogenesis, but not the selective growth or survival of a particular cell, by treatment with the NF-jB expression vector. These data suggest that NF-jB may have two independent effects, i.e., positive regulation of the gliogenic specification of mouse mesencephalic neural crest cells and the promotion of neural stem cell proliferation. NF-jB activity has been shown to be necessary for the myelin formation in Schwann cells (Nickols et al., 2003) and the survival of these cells (Boyle et al., 2005) in experiments using NF-jB mutant mice lacking the p65 subunit. Thus, NF-jB may be implicated in both gliogenic specification and Schwann cell differentiation. FGFs have been shown to promote gliogenic specification through Notch activation (Ijuin et al., 2008; Sugiura and Ito, 2010) . The gliogenic specification was suppressed by addition of the dn NF-jB expression vector or NF-jB siRNA in spite of the presence of the Notch-IC expression vector. Therefore, NF-jB acts on the pathway downstream of the Notch receptor in gliogenic specification. Furthermore, the suppression of gliogenesis by treatment with the dn NF-jB expression vector was recovered by the activation of Deltex-1, Hes1, or Hes5, the downstream components of the Notch receptor that participate in gliogenic specification (Ijuin et al., 2008) . In addition, the treatment with FGF2 or the Notch-IC expression vector did not only activate NF-jB but also expand the percentage of glial progenitor cells expressing NF-jB. These results suggest that NF-jB is activated by Notch-IC and acts on the pathway upstream of Deltex and Hes in the gliogenic specification of mouse mesencephalic neural crest cells (Fig. 9) . NF-jB has been shown to promote Deltex expression in B lymphocytes (Moran et al., 2007) . The number of Deltex-1-expressing cells was increased by the overexpression of NF-jB, and the proportion of glial progenitor cells in Deltex-1-expressing cells was increased by treatment with FGF2 or the Notch-IC expression vector. By contrast, treatment with the dn NF-jB expression vector prevented Deltex-1 expression under the overexpression of Notch-IC. It is possible that NF-jB stimulated by Notch-IC promotes Deltex-1 expression in the gliogenic specification (Fig. 9) .
B). (D) Expression pattern of Sox10 in the same field as (B) and (C). (E) DAPI-nuclear stain of the same field as (B), (C), and (D). (F) Merged image of (C), (D), and (E). (H) Expression pattern of Deltex-1 in the same field as (G). (I) Expression pattern of Sox10 in the same field as (G) and (H). (J) DAPI-nuclear stain of the same field as (G), (H), and (I). (K) Merged image of (H), (I), and (J). (B
Notch-IC activates NF-jB through the inhibition of IjB activity
It has been shown that Notch signaling up-regulates NF-jB activity in mouse bone marrow hematopoietic precursors (Cheng et al., 2001 ). The present data also showed that Notch-IC promoted NF-jB activity in mouse mesencephalic neural crest cells. Moreover, Notch-IC activates NF-jB by inhibiting the activity of IjB (Oakley et al., 2003) , a negative regulator of NF-jB (Nolan et al., 1991; Jacobs and Harrison, 1998) . Two types of mechanisms have been proposed with respect to NF-jB activation by Notch-IC through the inhibition of IjB activity. First, Vilimas et al. (2007) reported in an experiment using human T cell-derived CEM cells that Notch-IC activates IKK, which phosphorylates serine residues of IjB to cause degradation of IjB by a proteasome (Hayden and Ghosh, 2004; Perkins, 2007) . Second, Notch-IC blocks the binding of IjB to NF-jB by combining with NF-jB directly in HEK293T cells, and thereby promotes the nuclear retention of NF-jB (Shin et al., 2006) . In the latter study, NF-jB activity could be recovered by increasing the amounts of the Notch-IC expression vector, even in the presence of the SR IjB expression vector (Shin et al., 2006) . In the present study, however, the overexpression of Notch-IC never restored the suppression of gliogenesis by treatment with the SR IjB expression vector. This result suggests that Notch-IC may activate NF-jB by stimulating IKK in the gliogenic specification of mouse mesencephalic neural crest cells. The overexpression of wild-type IjB had a similar inhibitory effect to that of SR IjB on gliogenesis. The rate-limiting step in IjB inactivation has been shown to be the proteasome reaction (Traenckner et al., 1995) . Overexpressed wild-type IjB is phosphorylated by IKK but not degraded immediately. Therefore, it is conceivable that the overexpression of wild-type IjB prevents NF-jB activity, even under the activation of IKK by Notch-IC overexpression, and consequently gliogenic specification, similar to SR IjB.
3.3.
Notch-IC has two functions in the gliogeneic specification of the mecencephalic neural crest cells
The inhibition of gliogenesis by specific FGF signaling inhibitors or Notch-1 siRNA was not recovered by addition of the NF-jB expression vector, although NF-jB functions on the pathway downstream of the Notch receptor. However, this inhibition was restored by treatment with the Notch-IC expression vector. These results suggest that Notch-IC has dual functions in the gliogenic specification of mouse mesencephalic neural crest cells, i.e., the activation of NF-jB and the interaction with Deltex-1 (Fig. 9) . The blockage of Notch-IC formation by using Notch-1 siRNA prevented gliogenesis in the presence of the Deltex-1 expression vector. Furthermore, Deltex positively regulates Notch signaling through the interaction with the ankyrin repeats of Notch-IC (Matsuno et al., 1995). These data support our notion. The effect of NF-jB overexpression on gliogenesis was relatively modest compared with that of FGF treatment or Notch-IC overexpression. This may be due to dual functions of Notch-IC in the gliogenic specification. NF-jB overexpression promotes Deltex-1 expression but not Notch-IC formation. Accordingly, NF-jB overexpression alone has inadequate effect on the promotion of gliogenesis. Woodhoo et al. (2009) reported that Notch signaling activates Schwann cell transition from Schwann cell precursors rather than the gliogenic specification of neural crest cells. We cannot exclude the possibility that some crest cells generate Schwann cell precursors within the 4-day culture period and the Notch-NF-jB interaction promotes Schwann cell differentiation from these precursors.
3.4.
NF-jB and Deltex-1 exist in glial progenitor cells of the presumptive trigeminal ganglia
Mouse mesencephalic neural crest cells migrate to the presumptive trigeminal ganglia, colonize in this region, and undergo gliogenesis (Chan and Tam, 1988; Osumi-Yamashita et al., 1994; Le Douarin and Kalcheim, 1999) . This migration is completed by E8.5-9.0 (Chan and Tam, 1988; Serbedzija et al., 1992) . Our data show that glial progenitor cells contain NF-jB and Deltex-1 in the presumptive trigeminal ganglia at E9.0-9.5. Thus, the promotion of gliogenic specification by NF-jB may occur in the mouse presumptive trigeminal ganglia around E9.0-9.5.
4.
Experimental procedures
Primary cultures
Primary cultures of mesencephalic neural crest cells were prepared from E 8.0 (6-to 8-somite stage) ddY mouse embryos (Ito and Morita, 1995) . Neural folds at the mesencephalic levels were dissected and cut into fragments. These fragments were explanted in 35-mm culture dishes coated with a collagen gel (PureCol). Epithelial components in primary explants were scraped away with a tungsten needle after 48 h, leaving the emigrated mesencephalic neural crest cells on the substratum. The culture medium consisted of 85% a-modified minimum essential medium (a-MEM; Sigma), 10% FBS (Hyclone), 5% CEE, and 50 lg/ml gentamicin (Sigma). The cultures were incubated at 37°C in a humidified atmosphere containing 5% CO 2 . The culture medium was changed every other day. FGF2 (R&D Systems) was added to the medium at a concentration of 10 ng/ml. PD98059 (Calbiochem), rapamycin (Calbiochem), and SU5402 (Calbiochem) were used at 20 lM, 10 nM, and 5 lM, respectively.
Transfection of the expression vectors
Mouse mesencephalic neural crest cells were transfected with 1-2 lg of the following expression vectors: (1) the pCG-BL encoding the p65 subunit of NF-jB (a gift from Dr. K. Matsumoto; Suzawa et al., 2003) , (2) the pCG-BL encoding the p50 subunit of NF-jB (a gift from Dr. K. Matsumoto; Suzawa et al., 2003) , (3) the Rc-CMV encoding the dn mouse p50 (a gift from Dr. P. Chastagner; Logeat et al., 1991) , (4) the pcDNA3.1 encoding the mouse IjBa (a gift from Dr. B. A. Osborne; Shin et al., 2006) , (5) the pcDNA3.1 encoding the SR human IjBa (a gift from Dr. B. A. Osborne; Shin et al., 2006) , (6) the pcDNA3 encoding the mouse Notch-IC and a myc epitope (a gift from Dr. J. S. Nye et al., 1994; Foltz et al., 2002) , (7) the pCMV encoding the human Deltex-1 and a myc epitope (a gift from Dr. J. C. Aster; Izon et al., 2002) , (8) the pFLAG-CMV encoding the dn human Deltex-1 and a FLAG tag (a gift from Dr. J. C. Aster; Izon et al., 2002) , (9) the pCI encoding the mouse Hes1 (a gift from Dr. R. Takebayashi et al., 1994; Ohtsuka et al., 2001) , and (10) the pCMV encoding the rat Hes5 (a gift from Dr. R. Ohtsuka et al., 2001) . The transfection was performed by using Lipofectamine 2000 (Invitrogen) for the first 24 h or 48 h in culture. The transfection efficiencies of the vectors encoding a myc epitope or a FLAG tag were estimated by immunostaining with mouse anti-c-myc (9E10) (1:100; Santa Cruz Biotechnology) or mouse anti-FLAG-M2 (1:20; Sigma). The efficiencies of the vectors without tags were estimated by co-transfection with the pFP-C1 encoding Green Fluorescent Protein (GFP; Clontech) and immunostaining with rabbit anti-GFP (1:500; MBL). The transfection efficiency was presented as the proportion of cells expressing the myc epitope, FLAG tag, or GFP per total cells in a neural crest cell colony. The percentages of cells expressing the myc epitope, FLAG tag, and GFP reached 71.6 (±3.3)%, 72.2 (±2.8)%, and 78.7 (±3.65)%, respectively.
siRNA preparation
The siRNA was prepared as described previously (Nakanishi et al., 2007; Ijuin et al., 2008) . The siRNA duplexes for p50 subunit of NF-jB, Deltex-1, and Notch-1 were designed on the basis of p50, and Deltex-1, Notch-1 sequences published online [GeneBank Accession Nos. AY521463, NM008052, NM008714]. The sequences corresponded to (1) 
Luciferase reporter assays
To analyze the activity of NF-jB, we carried out luciferase reporter assays. Mouse mesencephalic neural crest cell cultures were treated with 1 lg of the pGL4.32[luc2P/NF-jB-RE/ Hygro] vector encoding the firefly luciferase reporter gene (luc2P) driven by five copies of an NF-jB enhancer element (Promega) during the first 48 h in culture. NF-jB activation has been known to stimulate the expression of luciferase encoded in the pGL4.32[luc2P/NF-jB-RE/Hygro] vector (Ferrè et al., 2010; Fushiki et al., 2010) . Since it was difficult to obtain enough number of cells to carry out routine biochemical assays of luciferase activity, the cultures were immunostained using goat anti-firefly luciferase (1:50; Promega) after transfection and then the number of cells expressing luciferase was counted. We used the pGL4.27[luc2P/minP/Hygro] encoding the luc2P only (Promega) as the control vector.
Immunostaining
Primary cultures of mouse mesencephalic neural crest cells were fixed with 4% paraformaldehyde (PFA) for 1 h on ice or with 10% formalin for 10 min at 4°C. The cultures were immunostained with the following primary antibodies: (1) rabbit anti-GFAP (1:100; DAKO), (2) mouse anti-neurofilament 68 kDa (1:12; Boehringer), (3) goat anti-collagen type II (1:50; Southern Biotechnology), (4) rabbit anti-p65 subunit of NF-jB (1:100; Santa Cruz Biotechnology), (5) mouse anti-p65 (1:50; Santa Cruz Biotechnology), (6) goat anti-firefly luciferase (1:50), (7) rabbit anti-Sox10 (1:100; Chemicon), and (8) goat anti-Deltex-1 (1:50; Santa Cruz Biotechnology). Primary antibodies were applied for 12 h at 4°C. The cultures were treated with the following secondary antibodies at room temperature for 1 h: (1) Alexa-488-conjugated donkey anti-rabbit IgG (1:500; Molecular Probes), (2) Alexa-488-conjugated donkey anti-goat IgG (1:500; Molecular Probes), (3) Alexa-488-conjugated goat anti-mouse IgG (1:500; Molecular Probes), (4) Alexa-555-conjugated donkey anti-rabbit IgG (1:500; Molecular Probes), (5) Alexa-555-conjugated donkey anti-goat IgG (1:500; Molecular Probes), and (6) Alexa-555-conjugated goat anti-mouse IgG (1:500; Molecular Probes). Mouse embryos were fixed with 4% PFA for 1-2 h on ice. The fixed embryos were immersed in gradually increasing concentration of sucrose solution and embedded in OCT compound (Miles). Cryostat sections were cut at 10 lm and mounted on albumin-coated glass slides. The sections were stained using the following primary antibodies: (1) mouse anti-p65, (2) goat anti-Deltex-1 (1:100), and (3) guinea pig anti-Sox10 (1:2000; a gift from Dr. M. Wegner; Maka et al., 2005) . Primary antibodies were applied for 12 h at 4°C. The specimens were treated with the following secondary antibodies at room temperature for 1 h: (1) Alexa-488-conjugated donkey anti-mouse IgG (1:1000), (2) Alexa-488-conjugated donkey anti-goat IgG (1:1000), and (3) rhodamine-conjugated donkey anti-guinea pig IgG (1:100; Chemicon). Finally, the cultures and sections were nuclearstained with 0.1 lg/ml DAPI (Dojindo). DAPI nuclear staining was particularly important for counting the exact number of immunoreactive cells in the neural crest cell cultures.
BrdU incorporation
BrdU-labeling experiments were performed to estimate cell proliferation in mouse mesencephalic neural crest cell cultures. BrdU (Wako) was prepared as a 1 mM stock solution in a-MEM and added to the cultures at a final concentration of 50 lM. The cultures were exposed to BrdU for 90 min and subsequently fixed in 4% PFA on ice for 1 h. BrdU-incorporated cells were detected with mouse anti-BrdU (1:10; Becton-Dickinson). In double-staining with anti-GFAP and anti-BrdU or with rabbit anti-p65 subunit of NF-jB and anti-BrdU, Alexa-488-conjugated donkey anti-rabbit IgG (1:500) and Alexa-555-conjugated donkey anti-mouse IgG (1:500) were used as secondary antibodies. The cultures were nuclear-stained with 0.1 lg/ml DAPI for the total cell count.
